B cells with immune-regulating function in transplantation

Nature Reviews Nephrology

Volumn 10, Issue 7, 2014, Pages 389-397

  Stolp, Jessica ^a   Turka, Laurence A ^b   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOPOIESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSPLANTATION;

ANIMALS; B-LYMPHOCYTES, REGULATORY; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; MICE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84903511143     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2014.80     Document Type: Review

References (97)

1. Jevnikar, A. M. & Mannon, R. B. Late kidney allograft loss: what we know about it, and what we can do about it. Clin. J. Am. Soc. Nephrol. 3 (Suppl. 2), S56-S67 (2008).
2. Bosmans, J. L. & Verpooten, G. A. Malignancy after kidney transplantation: still a challenge. Kidney Int. 71, 1197-1199 (2007). (Pubitemid 46884265)
3. Bottomley, M. J. & Harden, P. N. Update on the long-term complications of renal transplantation. Br. Med. Bull. 106, 117-134 (2013).
4. Sherston, S. N., Carroll, R. P., Harden, P. N. & Wood, K. J. Predictors of cancer risk in the long-term solid-organ transplant recipient. Transplantation 97, 605-611 (2014).
5. Wood, K. J., Bushell, A. & Hester, J. Regulatory immune cells in transplantation. Nat. Rev. Immunol. 12, 417-430 (2012).
6. Wood, K. J. & Goto, R. Mechanisms of rejection: current perspectives. Transplantation 93, 1-10 (2012).
7. Everly, M. J. et al. Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am. J. Transplant. 9, 1063-1071 (2009).
8. Mizoguchi, E., Mizoguchi, A., Preffer, F. I. & Bhan, A. K. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int. Immunol. 12, 597-605 (2000). (Pubitemid 30248892)
9. H1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167, 1081-1089 (2001). (Pubitemid 32660868)
10. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. & Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944-950 (2002). (Pubitemid 35154008)
11. Cooper, M. D., Peterson, R. D. & Good, R. A. Delineation of the thymic and bursal lymphoid systems in the chicken. Nature 205, 143-146 (1965).
12. Osmond, D. G. B cell development in the bone marrow. Semin. Immunol. 2, 173-180 (1990).
13. Schatz, D. G. & Baltimore, D. Uncovering the V(D)J recombinase. Cell 116 (Suppl. 2), S103-S106 (2004).
14. Tiegs, S. L., Russell, D. M. & Nemazee, D. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177, 1009-1020 (1993). (Pubitemid 23097390)
15. Loder, F. et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190, 75-89 (1999). (Pubitemid 29330125)
16. Merrell, K. T. et al. Identification of anergic B cells within a wild-type repertoire. Immunity 25, 953-962 (2006). (Pubitemid 44894955)
17. Zouali, M. The epigenetic landscape of B lymphocyte tolerance to self. FEBS Lett. 587, 2067-2073 (2013).
18. Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221-241 (2012).
19. Dalwadi, H. et al. B cell developmental requirement for the Gαi2 gene. J. Immunol. 170, 1707-1715 (2003). (Pubitemid 36197385)
20. Lampropoulou, V. et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180, 4763-4773 (2008).
21. Yanaba, K., Bouaziz, J. D., Matsushita, T., Tsubata, T. & Tedder, T. F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182, 7459-7472 (2009).
22. Zhang, X. Regulatory functions of innate-like B cells. Cell. Mol. Immunol. 10, 113-121 (2013).
23. O'Garra, A. et al. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22, 711-717 (1992).
24. - B cells: possible involvement in age-associated cytokine dysregulation. Int. Immunol. 9, 745-754 (1997). (Pubitemid 27226398)
25. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. & Bhan, A. K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219-230 (2002). (Pubitemid 34211962)
26. Lenert, P., Brummel, R., Field, E. H. & Ashman, R. F. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J. Clin. Immunol. 25, 29-40 (2005). (Pubitemid 40386176)
27. Mauri, C., Gray, D., Mushtaq, N. & Londei, M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197, 489-501 (2003). (Pubitemid 36278604)
28. Evans, J. G. et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178, 7868-7878 (2007). (Pubitemid 46898059)
29. Kalampokis, I., Yoshizaki, A. & Tedder, T. F. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 15 (Suppl. 1), S1 (2013).
30. Ding, Q. et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J. Clin. Invest. 121, 3645-3656 (2011).
31. Rafei, M. et al. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat. Med. 15, 1038-1045 (2009).
32. hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32, 129-140 (2010).
33. Iwata, Y. et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117, 530-541 (2011).
34. Lemoine, S., Morva, A., Youinou, P. & Jamin, C. Human T cells induce their own regulation through activation of B cells. J. Autoimmun. 36, 228-238 (2011).
35. Neves, P. et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33, 777-790 (2010).
36. + phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639-650 (2008). (Pubitemid 351636247)
37. Cohen-Sfady, M. et al. Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J. Immunol. 175, 3594-3602 (2005). (Pubitemid 41292018)
38. Deng, S. et al. Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J. Immunol. 178, 6028-6032 (2007). (Pubitemid 46717380)
39. + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178, 3447-3456 (2007). (Pubitemid 46417609)
40. 3 of Brugia pahangi. Int. Immunol. 17, 373-382 (2005). (Pubitemid 40568112)
41. Sato, S., Ono, N., Steeber, D. A., Pisetsky, D. S. & Tedder, T. F. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157, 4371-4378 (1996). (Pubitemid 126449355)
42. Martin, F. & Kearney, J. F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12, 39-49 (2000). (Pubitemid 30069213)
43. Matsumoto, M. et al. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 34, 703-714 (2011).
44. Bhattacharyya, S. et al. NFATc1 affects mouse splenic B cell function by controlling the calcineurin-NFAT signaling network. J. Exp. Med. 208, 823-839 (2011).
45. Yoshizaki, A. et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491, 264-268 (2012).
46. Yang, M. et al. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J. Immunol. 184, 3321-3325 (2010).
47. Gray, M., Miles, K., Salter, D., Gray, D. & Savill, J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl Acad. Sci. USA 104, 14080-14085 (2007). (Pubitemid 350003338)
48. Blair, P. A. et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 182, 3492-3502 (2009).
49. H17 but a decrease in regulatory T cells. J. Immunol. 186, 5569-5579 (2011).
50. Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. & Tedder, T. F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118, 3420-3430 (2008).
51. + regulatory T cells proceeds normally in the absence of B cells during EAE. Eur. J. Immunol. 42, 1164-1173 (2012).
52. H17 cell generation. Am. J. Pathol. 180, 2375-2385 (2012).
53. Carter, N. A., Rosser, E. C. & Mauri, C. Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res. Ther. 14, R32 (2012).
54. Moulin, V. et al. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J. Exp. Med. 192, 475-482 (2000). (Pubitemid 30666248)
55. Matsushita, T., Horikawa, M., Iwata, Y. & Tedder, T. F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 185, 2240-2252 (2010).
56. Saraiva, M. & O'Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181 (2010).
57. Zhao, G. et al. An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance. Am. J. Transplant. 10, 796-801 (2010)
58. + T cells: role of TGF-β 1. J. Immunol. 170, 5897-5911 (2003). (Pubitemid 36682569)
59. + T cells. Mucosal Immunol. 5, 691-701 (2012).
60. Shen, P. et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366-370 (2014).
61. Anel, A. et al. Apo2L/TRAIL and immune regulation. Front. Biosci. 12, 2074-2084 (2007).
62. Sharpe, A. H., Wherry, E. J., Ahmed, R. & Freeman, G. J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8, 239-245 (2007). (Pubitemid 46745373)
63. Ray, A., Basu, S., Williams, C. B., Salzman, N. H. & Dittel, B. N. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J. Immunol. 188, 3188-3198 (2012).
64. Vas, J., Gronwall, C., Marshak-Rothstein, A. & Silverman, G. J. Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes. Arthritis Rheum. 64, 3388-3398 (2012).
65. Chen, Y. et al. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol. 183, 1346-1359 (2009).
66. A14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997). (Pubitemid 27516282)
67. Sonoda, K. H. & Stein-Streilein, J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32, 848-857 (2002). (Pubitemid 34257562)
68. Bialecki, E. et al. Role of marginal zone B lymphocytes in invariant NKT cell activation. J. Immunol. 182, 6105-6113 (2009).
69. α19i T cells regulate autoimmune inflammation. Nat. Immunol. 7, 987-994 (2006). (Pubitemid 44263913)
70. + B cells is essential for the maintenance of invariant natural killer T cells. Immunity 36, 477-490 (2012).
71. Gregori, S. et al. Differentiation of type 1, T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116, 935-944 (2010).
72. H2 cytokine expression in long-term accepted grafts. Transplantation 73, 1123-1130 (2002). (Pubitemid 34415447)
73. Liu, C. et al. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat. Med. 13, 1295-1298 (2007). (Pubitemid 350073600)
74. Le Texier, L. et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am. J. Transplant. 11, 429-438 (2010).
75. Fehr, T. et al. Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II. J. Immunol. 181, 165-173 (2008).
76. Fehr, T. et al. Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells. J. Immunol. 181, 4371-4380 (2008).
77. Huang, X. et al. Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance. Transplantation 85, 675-680 (2008). (Pubitemid 351398242)
78. Xiao, S. et al. Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J. Exp. Med. 204, 1691-1702 (2007). (Pubitemid 47048034)
79. DiLillo, D. J. et al. B lymphocytes differentially influence acute and chronic allograft rejection in mice. J. Immunol. 186, 2643-2654 (2011).
80. Newell, K. A. et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120, 1836-1847 (2010).
81. Sagoo, P. et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J. Clin. Invest. 120, 1848-1861 (2010).
82. Pallier, A. et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int. 78, 503-513 (2010).
83. Silva, H. M. et al. Preserving the B-cell compartment favors operational tolerance in human renal transplantation. Mol. Med. 18, 733-743 (2012).
84. Chesneau, M. et al. Unique B cell differentiation profile in tolerant kidney transplant patients. Am. J. Transplant. 14, 144-155 (2014).
85. Haneda, M. et al. Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone. Transplantation 97, 405-412 (2014).
86. Brouard, S. et al. The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am. J. Transplant. 12, 3296-3307 (2012).
87. Clatworthy, M. R. et al. B-cell-depleting induction therapy and acute cellular rejection. N. Engl. J. Med. 360, 2683-2685 (2009).
88. Deng, J. & Galipeau, J. Reprogramming of B cells into regulatory cells with engineered fusokines. Infect. Disord. Drug Targets 12, 248-254 (2012).
89. Van de Velde, H., von Hoegen, I., Luo, W., Parnes, J. R. & Thielemans, K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 351, 662-665 (1991). (Pubitemid 21896665)
90. Bikah, G., Carey, J., Ciallella, J. R., Tarakhovsky, A. & Bondada, S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274, 1906-1909 (1996). (Pubitemid 26424770)
91. Depoil, D. et al. CD19 is essential for B cel activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat. Immunol. 9, 63-72 (2008). (Pubitemid 350286205)
92. Henchoz-Lecoanet, S. et al. The Epstein-Barr virus-binding site on CD21 is involved in CD23 binding and interleukin-4-induced IgE and IgG4 production by human B cells. Immunology 88, 35-39 (1996). (Pubitemid 26166374)
93. Tedder, T. F., Zhou, L. J. & Engel, P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15, 437-442 (1994). (Pubitemid 24272189)
94. Spiegelberg, H. L. Fce R2/CD23: its discovery and possible functions. Monogr. Allergy 29, 1-8 (1991).
95. Liu, Y. et al. Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J. Exp. Med. 175, 437-445 (1992).
96. hi and exhibit unique signaling characteristics. J. Immunol. 149, 2533-2540 (1992).
97. Sims, G. P. et al. Identification and characterization of circulating human transitional B cells. Blood 105, 4390-4398 (2005). (Pubitemid 40720786)